Chris Picariello
President @ Johnson & Johnson Innovation
New Brunswick, United States
Chris Picariello is a Series B investor at Johnson & Johnson Innovation in New Brunswick focused on Medical and Health Care. Chris Picariello is the President at Johnson & Johnson Innovation.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Chris Picariello invests in
Stages Chris Picariello invests in
Countries Chris Picariello invests in
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aro Biotherapeutics
|
Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases. Centyrins are small, non-antibody protein scaffolds that can be expressed as multi-specifics with novel therapeutic mechanisms of action.Centyrins are also ideal for the targeted delivery of complex drug payloads, including nucleic acids. | $41.5M / Series B / Nov 28, 2023 |
Co-Investors
About Johnson & Johnson Innovation
Johnson & Johnson Innovation accelerates early-stage innovation through strategic collaboration. It connects potential collaborators to resources with the goal of assisting them in advancing transformation science and technology across the pharmaceutical, medical device, and consumer healthcare spectrums.
Johnson & Johnson Innovation Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Chris Picariello
President
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Chris Picariello invest in?
Chris Picariello invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Chris Picariello last invest?
The most recent investment recorded for Chris Picariello closed in Nov 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
